Algo version: 0.98b
Sansure Biotech Inc. is listed at the SHH Exchange
Sansure Biotech Inc. [688289.SS]
SHH Sector: Healthcare Industry:Medical Instruments & Supplies

Is Sansure Biotech Inc. stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Sansure Biotech Inc. pays dividends. Last time was Tuesday 11th of June 2024 where the investors holding the stock on Tuesday 11th of June 2024 were paid CNY0.2 per share. Over the last 8 times between 2020 and 2024, Sansure Biotech Inc. has paid CNY4.19019 with an average of CNY0.52 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Sansure Biotech Inc. 10 years ago, but if you had invested on Friday 28th of August 2020 when the price was CNY78.42, you would have made a loss of CNY-61.21 per share or -78.05%

Yes, the average daily trading liquidity for Sansure Biotech Inc. is CNY3.32 million. You should therefore be able to get in and out of your positions relatively fast.

Sansure Biotech Inc. has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.11, the company's ability to pay off the debt is normal. Sansure Biotech Inc. has a very good net profit margin of 32.12% and should have very high tolerances against inflation.

We have calculated the inflation risk for Sansure Biotech Inc. to be low [0.15 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.